drugset / Trial / NCT03204994

Fluorescence Targeted Pelvic Lymph Node Mapping

NCT03204994

Phase 1/2 Terminated 1 enrolled Oxford University Hospitals NHS Trust
NaSingle-groupOpen-labelTreatment

Summary

This study aims to assess the lymphatic drainage of rectal tumours by using ICG as a fluorescent non-specific marker. As a feasibility study, it will also assess its technique and timing along with its ability to assist in removing lymph nodes when it is clinically indicated.

Timeline

Start
2017-08-01
Primary completion
2018-07-01
Completion
2018-08-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Indocyanine Green Diagnostic / imaging agent Other